Endoscopic vessel harvesting is a surgical procedure, which can be used in combination with coronary artery bypass surgery. It is considered to be amongst the most minimally invasive technique thanother methods.Furthermore, it also requires a single 2cm incision and added with one or two smaller incisions of about 2-3 mm in length. EVH involves the accuracy in cutting and sealing off the smaller blood vessels that branch off the main network prior to the removal from the body. This procedure does not affect or harms the remaining blood vessel network, and hence completely heals quickly, safeguarding the patients from further damage. It also poses reduced risk of infection, lesser post-operative pain or swelling, least wound complications, minimal scarring and hence offering faster recovery than other methods
COVID-19 scenarioanalysis:
Pharmaceutical and biotechnological companies have joined hands with governments around the globe and are fighting with the pandemic situation. The outbreak of the pandemic led to a lockout situation causing reduction in the number of surgical procedures in order to reduce the spread of infection. COVID-19 is anticipated to have noteworthy long-term impacts on the healthcare industry. Countries and major players would have to undertake serious healthcare variations until the crisis takes a back seat and hence improve the current situation. Technological advancement, ensuring the availability of the resources, cost containment and increased access will in the near future be an integral part of healthcare improvements. The pandemic led to severe resource restraints. This is projected to result in the development of competitive pricing and value-based pricing models, which will hasten the market growth in future.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The market is driven by key factors such as rise in the prevalence and incidences of cardiovascular diseases and rise in the preference for the minimally invasive procedures which showcases better advantages that it offers over conventional methods would help the market propel in the coming years. The growth in the adoption of unhealthy lifestyle which is among the major risk factor causing cardiovascular diseases is anticipated to help the market grow in the near future. However, stringent government regulations may hamper the growth of the industry during the forecast period.
The global endoscopic vessel harvesting market trends are as follows:
Rise in incidences of cardiovascular diseases to flourish the market
The rise in the prevalence and incidences of the cardiovascular diseases would help the market boost in the coming years. Furthermore, the steep increase in the inclination toward the minimally invasive procedures, which offer greater advantages than the conventional methods, is anticipated to help the market grow significantly. The surge in the population mainly geriatric who are susceptible to experience cardiovascular diseases would boost the industry in the forecast period. However, the stringent government regulations may impede the growth of the industry in the coming years
Hike in mergers and acquisition to boost the market
The increase in the mergers and acquisitions carried out by the major players is anticipated to help the market grow in the forecast period. For instance, in February 2018, LivaNova plc. acquired TandemLife, which is a privately-held corporationengrossed on advanced cardiopulmonary temporary sustenance solutions (TandemLife). Furthermore, the Pittsburgh-based company showcases about four product systems, which are all built around a shared pump and also a controller. These systems, which contain Extracorporeal Life Support and Percutaneous Mechanical Circulatory Support, are conforming to LivaNova’s resilient offerings in the cardiac surgery.
In addition, in June 2018, Saphena Medical Inc. offered a group purchasing agreement with Premier, which is a national healthcare development company. In addition, Saphena Medical's Venapax Endoscopic Vessel Harvesting Devices System is among the first unitary EVH system available in the market. It is proved to help for the saphenous vein or radial artery to be harvested for a CABG procedure in only a single comprehensive system. This contract gives Premier members entree to pre-negotiated valuing for the Venapax system.
Key benefits of the report:
- This study presents the analytical depiction of the global Endoscopic Vessel Harvesting industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Endoscopic Vessel Harvesting market share.
- The current market is quantitatively analyzed to highlight the global Endoscopic Vessel Harvesting market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the Endoscopic Vessel Harvestingmarket.
- The report provides a detailed global Endoscopic Vessel Harvesting market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Endoscopic Vessel Harvesting Market research report:
- What are the leading market players active in the Endoscopic Vessel Harvestingmarket?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in tasking further strategic steps?
Endoscopic Vessel Harvesting Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Technique |
|
 By Vessel types |
|
 By Usability |
|
 By Applications |
|
 By Region |
|
 Key Market Players | LivaNova plc., Saphena Medical,, KARL STORZ,, Maquet Holding B.V. & Co. KG.,, Getinge,, Cardio Medical,, Sorin Group, Inc., Med Europe S.r.l,, Medical Instruments Spa Terumo Cardiovascular Systems Corporation,, OLYMPUS CORPORATION, |
Loading Table Of Content...
